DSIP: reference dosing schedule
> Updated:
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
In research and clinical sources DSIP is given subcutaneously, usually in the evening 30–120 minutes before bed. The figures below are a generalized reference drawn from described protocols and case reports, not controlled trials.
This is a concise reference to regimens described for adults; it is not an individual prescription.
DSIP dosing in the gathered sources is always tied to evening timing rather than spread through the day, matching the compound's very short half-life and its studied role in the sleep-onset window rather than in maintaining a steady blood level.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | 100 mcg SubQ, evening before bed | Starting dose |
| Standard regimen | 250 mcg SubQ, evening before bed | Increase if needed |
| Upper bound | up to 500 mcg SubQ | Maximum in this schedule |
Background on the molecule, its mechanism and primary sources is covered in the monograph.
Practical dosing and effect details
DSIP (Delta Sleep-Inducing Peptide) is described mostly in the context of the physiological sleep-onset window, so regimens from public sources call for one evening injection, 30-120 minutes before bed, rather than several doses a day. That sets it apart from most other research peptides on this site, where the dose is split across multiple daily injections.
The escalation on this page, from 100 mcg at the start to 250 mcg in the standard regimen and up to 500 mcg as the upper bound, leaves the timing unchanged: only the amount per evening injection changes, not the frequency. DSIP, a short nonapeptide of nine amino acids, clears from blood quickly, so a single evening injection is timed to the sleep-onset window rather than meant to hold a steady concentration until morning. Controlled human trials of DSIP are lacking, so the figures above summarize community observations and protocols rather than a randomized study.
This is reference information for planning a research protocol, not a medical recommendation and not instructions for self-administration.
This reference is research-use material. The information is not medical advice and is not intended for diagnosis, treatment or prevention of disease.